R&D and Clinical Solutions Resources

Speed is key in life science product development. Delays cost, as do mistakes. With independent clinical consultants, neither has to be an issue.

The Head of Regulatory Affairs at a F500 biotech was looking to mature the regulatory affairs function and needed a consultant to lead a transformation from current to desired state. They needed...

The chief of staff for the quality organization of an F200 life science company needed to establish and implement a compliant workstream related to the specific requirements of current in-vitro...

A Fortune 500 pharmaceutical company was looking to build a pharmacovigilance organization that was flexible and proactive to respond in an increasingly challenging and ever-changing environment...

A Fortune 500 pharmaceutical company was looking to understand the regulatory, legal, pricing, and market access rules, opportunities, and challenges for developing fixed-dose combinations and...

A Fortune 500 medical device company needed external expertise to evaluate the company’s current standing and provide feedback to improve best practices, competencies, and procedures for new...

The R&D strategy and Operations team at a large pharma company had developed a high-level vision and detailed design plan for their Continuous Improvement (CI) Program and needed help implementing...

The Discovery Research Project Team within the Clinical Development business unit at an F200 pharma company was stretched thin and needed additional project management capacity support for...

A global pharma company had multiple early phase assets in the pipeline. While developing the commercial strategy in parallel, the business acceleration team wanted to understand potential digital...

The portfolio performance and analytics group of an F200 biotechnology company needed a consultant to support their annual portfolio review. This would entail deep analysis, insights to guide...

The regulatory group within a large international pharmaceutical company was developing a new dosing medical device and needed a consultant to guide the team on design control and regulatory...

The clinical development group of an F500 pharmaceutical company was undergoing a transformation to improve patient experience, integrate information, develop a scalable meta-platform supporting...

Data-driven insights are key to flourish in the post-pandemic economy, but it can be challenging to find resources to harness those insights effectively.

Digital health has grown and evolved rapidly in the past decade—spurred by exciting developments in AI, machine learning, and the internet of things (IoT), alongside nearly ubiquitous adoption of smar

Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.

A senior director in R&D at an F100 pharma company wanted to conduct a landscape analysis of technology trends and innovation impacting Phase 3 clinical trials in immunology to improve speed,...